Trial · NCT07887399
New Treatment in Melasma
NCT07887399, Not applicable, Not yet recruiting, Sohag University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. New Treatment in Melasma. Trials, record NCT07887399. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887399
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- New Treatment in Melasma
- NCT number
- NCT07887399
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 75 participants, estimated
- Lead sponsor
- Sohag University
- Conditions
- Female, With, Facial, Melasma
- Interventions
- Tranexamic Acid - topical, Microneedling with Topical Tranexamic acid, Modified Kligman's Formula
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Melasma Area and Severity Index (MASI) score from baseline to the end of the treatment period | 4 months after initiation of treatment | The mean change in MASI score from baseline to the end of the treatment period (4 months) will be compared among the three treatment groups. |
| Secondary | Percentage change in Melasma Area and Severity Index (MASI) from baseline to the end of treatment | 4 months after initiation of treatment | The percentage change in MASI score from Baseline to the end of the treatment period will be calculated for each participant and compared among the three treatment groups. |
| Secondary | Patient Satisfaction assessed using a 4-point patient satisfaction scale | 4 months after initiation of treatment | Patient satisfaction with treatment results will be assessed at the end of the treatment period using a 4-point scale: excellent(\>75% improvement), good(51-75% improvement), fair (26-50% improvement), and poor (0-25% improvement). |
| Secondary | Incidence of treatment-related adverse events | from initiation of treatment to the end of the treatment period(4months) | Treatment safety will be assessed by recording the incidence and types of adverse events, including erythema, irritation, burning, dryness and post-inflammatory hyperpigmentation |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887399
GET https://conductscience.org/api/trials/v1/NCT07887399/registered